Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14
Clinical trial NCT02860936 · COMPLETED
Trial details
- NCT number
- NCT02860936
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2019-06-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.